Smith & Nephew SNATS (SNN) Competitors $31.66 +0.19 (+0.59%) Closing price 07/25/2025 03:59 PM EasternExtended Trading$31.68 +0.01 (+0.03%) As of 07/25/2025 05:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SNN vs. GEHC, PHG, ZBH, SOLV, PEN, STVN, GKOS, BLCO, IRTC, and SLNOShould you be buying Smith & Nephew SNATS stock or one of its competitors? The main competitors of Smith & Nephew SNATS include GE HealthCare Technologies (GEHC), Koninklijke Philips (PHG), Zimmer Biomet (ZBH), Solventum (SOLV), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Bausch + Lomb (BLCO), iRhythm Technologies (IRTC), and Soleno Therapeutics (SLNO). These companies are all part of the "medical equipment" industry. Smith & Nephew SNATS vs. Its Competitors GE HealthCare Technologies Koninklijke Philips Zimmer Biomet Solventum Penumbra Stevanato Group Glaukos Bausch + Lomb iRhythm Technologies Soleno Therapeutics GE HealthCare Technologies (NASDAQ:GEHC) and Smith & Nephew SNATS (NYSE:SNN) are both large-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, media sentiment, earnings, institutional ownership, dividends, valuation and risk. Which has more volatility & risk, GEHC or SNN? GE HealthCare Technologies has a beta of 1.14, suggesting that its share price is 14% more volatile than the S&P 500. Comparatively, Smith & Nephew SNATS has a beta of 0.69, suggesting that its share price is 31% less volatile than the S&P 500. Which has better earnings and valuation, GEHC or SNN? GE HealthCare Technologies has higher revenue and earnings than Smith & Nephew SNATS. Smith & Nephew SNATS is trading at a lower price-to-earnings ratio than GE HealthCare Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGE HealthCare Technologies$19.67B1.81$1.99B$4.7516.34Smith & Nephew SNATS$5.81B2.39$412M$2.1614.66 Is GEHC or SNN a better dividend stock? GE HealthCare Technologies pays an annual dividend of $0.14 per share and has a dividend yield of 0.2%. Smith & Nephew SNATS pays an annual dividend of $0.89 per share and has a dividend yield of 2.8%. GE HealthCare Technologies pays out 2.9% of its earnings in the form of a dividend. Smith & Nephew SNATS pays out 41.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. GE HealthCare Technologies has increased its dividend for 1 consecutive years. Does the media refer more to GEHC or SNN? In the previous week, GE HealthCare Technologies had 15 more articles in the media than Smith & Nephew SNATS. MarketBeat recorded 18 mentions for GE HealthCare Technologies and 3 mentions for Smith & Nephew SNATS. GE HealthCare Technologies' average media sentiment score of 1.42 beat Smith & Nephew SNATS's score of 1.21 indicating that GE HealthCare Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GE HealthCare Technologies 14 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Smith & Nephew SNATS 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is GEHC or SNN more profitable? GE HealthCare Technologies has a net margin of 11.02% compared to Smith & Nephew SNATS's net margin of 0.00%. GE HealthCare Technologies' return on equity of 24.95% beat Smith & Nephew SNATS's return on equity.Company Net Margins Return on Equity Return on Assets GE HealthCare Technologies11.02% 24.95% 6.38% Smith & Nephew SNATS N/A N/A N/A Do insiders and institutionals have more ownership in GEHC or SNN? 82.1% of GE HealthCare Technologies shares are owned by institutional investors. Comparatively, 25.6% of Smith & Nephew SNATS shares are owned by institutional investors. 0.3% of GE HealthCare Technologies shares are owned by company insiders. Comparatively, 1.0% of Smith & Nephew SNATS shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Do analysts recommend GEHC or SNN? GE HealthCare Technologies presently has a consensus target price of $88.55, indicating a potential upside of 14.09%. Smith & Nephew SNATS has a consensus target price of $28.00, indicating a potential downside of 11.57%. Given GE HealthCare Technologies' stronger consensus rating and higher probable upside, equities research analysts plainly believe GE HealthCare Technologies is more favorable than Smith & Nephew SNATS.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score GE HealthCare Technologies 0 Sell rating(s) 3 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.83Smith & Nephew SNATS 0 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryGE HealthCare Technologies beats Smith & Nephew SNATS on 17 of the 20 factors compared between the two stocks. Get Smith & Nephew SNATS News Delivered to You Automatically Sign up to receive the latest news and ratings for SNN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SNN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SNN vs. The Competition Export to ExcelMetricSmith & Nephew SNATSMED PRODUCTS IndustryMedical SectorNYSE ExchangeMarket Cap$13.79B$10.55B$5.69B$21.10BDividend Yield2.81%2.00%4.58%3.59%P/E Ratio14.6617.0728.1028.44Price / Sales2.3929.17432.4458.59Price / Cash9.9723.0336.2222.92Price / Book2.633.698.664.69Net Income$412M$234.77M$3.25B$995.51M7 Day Performance5.06%6.32%4.23%1.65%1 Month Performance4.86%7.94%10.52%4.54%1 Year Performance9.45%-13.57%34.41%9.99% Smith & Nephew SNATS Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SNNSmith & Nephew SNATS2.7209 of 5 stars$31.67+0.6%$28.00-11.6%+9.4%$13.79B$5.81B14.6617,349News CoveragePositive NewsGEHCGE HealthCare Technologies4.2644 of 5 stars$74.45-0.9%$88.55+18.9%-2.9%$34.09B$19.80B15.6753,000Positive NewsUpcoming EarningsPHGKoninklijke Philips2.7208 of 5 stars$24.07+0.1%N/A+1.6%$23.17B$17.98B55.9766,678Upcoming EarningsZBHZimmer Biomet4.9443 of 5 stars$93.79flat$110.00+17.3%-11.8%$18.56B$7.68B20.7517,000Positive NewsSOLVSolventum0.768 of 5 stars$74.08+0.4%$81.50+10.0%+29.9%$12.82B$8.25B34.3022,000Positive NewsPENPenumbra4.4474 of 5 stars$238.82+0.4%$305.07+27.7%+22.7%$9.25B$1.24B225.314,500Positive NewsUpcoming EarningsInsider TradeSTVNStevanato Group1.3232 of 5 stars€25.55+1.3%N/A+32.3%€7.74B€1.12B50.105,521News CoverageGKOSGlaukos4.2468 of 5 stars$104.43+0.6%$134.67+29.0%-19.9%$5.97B$404.52M-44.06780Positive NewsUpcoming EarningsBLCOBausch + Lomb1.8866 of 5 stars$13.67-1.5%$15.45+13.1%-8.3%$4.83B$4.83B-13.2713,500Upcoming EarningsIRTCiRhythm Technologies1.0226 of 5 stars$138.91+2.2%$138.60-0.2%+41.3%$4.43B$591.84M-44.242,000Upcoming EarningsSLNOSoleno Therapeutics4.1957 of 5 stars$82.76+1.5%$108.70+31.3%+84.2%$4.17BN/A-17.9130Positive NewsAnalyst UpgradeHigh Trading Volume Related Companies and Tools Related Companies GE HealthCare Technologies Competitors Koninklijke Philips Competitors Zimmer Biomet Competitors Solventum Competitors Penumbra Competitors Stevanato Group Competitors Glaukos Competitors Bausch + Lomb Competitors iRhythm Technologies Competitors Soleno Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:SNN) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Create New Advertiser | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Smith & Nephew SNATS, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Smith & Nephew SNATS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SNN Stock Alerts